Latest Als News

MetalsTech Limited is progressing its Pre-Feasibility Study for the Sturec Gold Mine in Slovakia, targeting completion in the first half of 2026, alongside key board appointments aimed at driving the project forward.

Stellar Resources has reported significant progress in its December quarter, advancing the Heemskirk Tin Project through robust drilling results and metallurgical studies, supported by a $9.5 million capital raise.

Eclipse Metals has initiated metallurgical testing on its Grønnedal Rare Earths Project in Greenland, focusing on magnetic separation techniques to unlock the deposit’s potential. Core samples from recent drilling are en route to Perth for analysis, while strategic engagement with global partners continues.

OzAurum Resources has reported promising assay results from its James Stage 1 open pit drilling at Mulgabbie North, confirming consistent shallow high-grade gold mineralisation and supporting a near-term, low-cost heap leach development strategy.

Gold Mountain Limited has reported strong assay results from diamond drilling at its Irajuba IR-1 prospect in Brazil, extending known rare earth mineralisation beyond previous targets with notably high magnet rare earth oxide content.

Tambourah Metals has reported impressive high-grade gold intersections at its Tambourah Gold Project in Western Australia, highlighting strong potential for an initial resource estimate. Diamond drilling results confirm continuity of mineralisation at Tambourah King and promising findings at Alexandria and Young Australian prospects.

Magnum Mining has resumed drilling at its Palmares and Azimuth rare earth projects in Brazil, advancing high-grade targets with assay results expected by the end of January.

Patagonia Lithium has reached 335 metres depth in its Formentera lithium brine drilling program in Argentina, successfully collecting brine and core samples for detailed analysis. The company plans further drilling and geophysical surveys to refine its Mineral Resource Estimate.

Neurizon Therapeutics has progressed its ALS treatment NUZ-001 into critical clinical trial phases, even as the FDA declines its Fast Track Designation request pending more data.

Alara Resources' joint venture in Oman is under legal scrutiny as local residents seek to halt operations and challenge project licences. The company disputes the claims and continues production while monitoring developments.

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Neurizon Therapeutics has locked in a $44 million funding package to fully support its lead drug NUZ-001 in the HEALEY ALS Platform Trial, marking a critical step toward potential regulatory approval and broader neurodegenerative applications.